Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySat, 27 Jul 2024 00:31:03 +0200Fri, 26 Jul 2024 12:00:00 +0200Human medicines European public assessment report (EPAR): Ranibizumab Midas, ranibizumab, Status: Opinionhttps://www.ema.europa.eu/en/medicines/human/EPAR/ranibizumab-midasHuman medicines European public assessment report (EPAR): Ranibizumab Midas, ranibizumab, Status: Opinionhttps://www.ema.europa.eu/en/medicines/human/EPAR/ranibizumab-midasFri, 26 Jul 2024 12:00:00 +0200Human medicine